Novo Nordisk | Liquidités



Cash And Equivalent Changement Date
ANI Pharmaceuticals USD 217.8M 67.99M 2025-06
Aurora Cannabis CAD 140.16M 31.45M 2025-06
Bausch Health Companies USD 1.73B 593M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Canopy Growth CAD 126.2M 109.89M 2025-06
Corcept Therapeutics USD 102.74M 12.93M 2025-06
Drreddys Laboratories INR 9B 7.91B 2025-06
Eli Lilly USD 3.38B 282.6M 2025-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
Merck USD 8.01B 622M 2025-06
Novartis USD 6.66B 410M 2025-06
Novo Nordisk 38.94B 18.08B 2025-03
Novo Nordisk A/S 18.44B 5.78B 2025-06
Pacira USD 300.48M 16.87M 2025-06
Perrigo USD 454.2M 44.3M 2025-06
Prestige Brands USD 139.5M 41.62M 2025-06
Sanofi 15.36B 7.37B 2025-06
Supernus Pharmaceuticals USD 144.71M 28.86M 2025-06
Zoetis USD 1.44B 286M 2025-06


Novo Nordisk Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.